Patents by Inventor Eric Raspé

Eric Raspé has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SENSITIVITY TO A CDK4/6 INHIBITOR
    Publication number: 20190345558
    Abstract: The present invention relates to a method for determining sensitivity to a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor in a human subject having breast cancer, the method comprising determining in a sample from the subject the level of expression of 11 genes as defined in the claims. The present invention further provides kits of parts, nucleic acid arrays, and uses thereof for determining sensitivity to a CDK4/6 inhibitor in a human subject having breast cancer. The present invention also relates to methods of treating a human subject having breast cancer, comprising administering a therapeutically effective amount of the CDK4/6 inhibitor to the subject.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 14, 2019
    Inventors: Eric RASPÉ, Pierre Philippe ROGER, Katia COULONVAL, Sabine PATERNOT, Jaime Miguel GOMES PITA, Christos SOTIRIOU, Michail IGNATIADIS, Françoise ROTHÉ
  • Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process
    Patent number: 6528538
    Abstract: The present invention relates to cyclic compounds which are of the class of compounds of formula I wherein X and Y represent an oxygen atom and to processes for preparing such compounds. The compounds are useful in the treatment of dyslipidemia, atherosclerosis, and diabetes.
    Type: Grant
    Filed: January 16, 2001
    Date of Patent: March 4, 2003
    Assignee: Merck Patentgesellschaft
    Inventors: Jean-Jacques Zeiller, Jean-Jacques Berthelon, Eric Raspé, Daniel Guerrier